Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Philips Museum Launches Interactive AI Exhibition: brAInpower

(IN BRIEF) The Philips Museum in Eindhoven, Netherlands, is set to unveil its new exhibition, ‘brAInpower,’ on April 20th, focusing on artificial intelligence (AI) and its impact, particularly in healthcare. Through interactive elements, rare collection pieces, and informative videos, visitors … Read the full press release

Advancements in Causal Machine Learning Poised to Revolutionize Medical Diagnostics and Therapy, Researchers Say

(IN BRIEF) An international research group, led by Professor Stefan Feuerriegel from LMU, is pioneering the application of causal machine learning (ML) in medical diagnostics and therapy. Published in Nature Medicine, their study asserts that causal ML has the potential … Read the full press release

University of Liverpool Awarded £1.3m to Combat Antimicrobial Resistance in Fleming Fund Partner Countries

(IN BRIEF) The University of Liverpool has secured £1.3m in funding to support the UK Government’s Fleming Fund Fellowship Programme, aimed at addressing antimicrobial resistance (AMR) in partner countries. Led by Professor Alison Holmes, the program will provide mentorship and … Read the full press release

Sanofi’s Frexalimab Shows Promise in Phase 2 for Treating Multiple Sclerosis

(IN BRIEF) Sanofi’s experimental CD40L antibody, frexalimab, demonstrates encouraging results in a 48-week phase 2 study for relapsing multiple sclerosis (MS). Presented at the American Academy of Neurology Annual Meeting, the data reveals sustained reduction in disease activity and favorable … Read the full press release

Long-Term Study Shows Sustained Efficacy of Kesimpta in Treating Relapsing Multiple Sclerosis

(IN BRIEF) Novartis revealed promising data from the ALITHIOS open-label extension study, highlighting the enduring effectiveness of Kesimpta® (ofatumumab) in treating relapsing multiple sclerosis (RMS) over a span of up to six years. The study, presented at the American Academy … Read the full press release

AstraZeneca’s IMPACT CKD Model Forecasts Alarming Rise in Chronic Kidney Disease by 2032

(IN BRIEF) AstraZeneca’s IMPACT CKD model predicts a significant increase in chronic kidney disease (CKD) across eight countries, with up to 16.5% of the population affected by 2032, including a substantial rise in advanced-stage cases. Presented at the 2024 ISN … Read the full press release

Advancing Healthcare: Bosch and Randox Labs Partner to Revolutionize Molecular Diagnostics

(IN BRIEF) Bosch and Randox Laboratories Ltd. have forged a strategic partnership aimed at transforming molecular diagnostics with a focus on the Vivalytic analysis platform. With an investment of 150 million euros in joint research, development, and distribution, the collaboration … Read the full press release

EBRD Invests €22 Million to Propel Farmak’s Expansion into Polish Market

(IN BRIEF) The European Bank for Reconstruction and Development (EBRD) has provided a €22 million loan to Ukrainian pharmaceutical giant Farmak Group to facilitate its strategic acquisition of a Polish pharmaceutical company and to upgrade its IT systems. Farmak, a … Read the full press release

Philips Reaches Final Agreement on Consent Decree for Respironics Business with DOJ and FDA

(IN BRIEF) Royal Philips announces the final agreement on a consent decree for its subsidiary, Philips Respironics, with the US Department of Justice (DOJ) and the US Food and Drug Administration (FDA). The decree primarily focuses on Respironics’ US operations, … Read the full press release

Study Reveals High Rates of Repeat Antibiotic Prescriptions for Respiratory Tract Infections in UK Primary Care

(IN BRIEF) A recent study conducted by researchers from the Universities of Bristol and Bath, King’s College London, and University Medical Center Utrecht highlights the concerning prevalence of repeat antibiotic prescriptions for respiratory tract infections (RTIs) within the same episode … Read the full press release

Infant Brain Responses to Speech Predict Later Language Development, Study Finds

(IN BRIEF) A study conducted at the University of Helsinki under the DyslexiaBaby project reveals that infants’ neural responses to speech sounds can predict their later development of language and literacy skills. Stronger neural responses in the left side of … Read the full press release

Breakthrough Study: Single Genetic Test Offers Early Diagnosis for Children with Rare Disorders

(IN BRIEF) A groundbreaking study led by researchers from the University of Exeter, the Wellcome Sanger Institute, and the University of Cambridge introduces a novel approach to genetic testing, potentially revolutionizing the diagnosis of rare developmental disorders in children. By … Read the full press release

WACKER and Pantherna Collaborate to Ramp Up mRNA Production for ARDS Treatment

(IN BRIEF) WACKER’s mRNA competence center in Halle is gearing up to produce an active ingredient for combatting acute respiratory distress syndrome (ARDS) in collaboration with Pantherna Therapeutics. The center, equipped with four new production lines, will more than triple … Read the full press release

AstraZeneca’s Imfinzi Shows Promising Results in Phase III Trial for Small Cell Lung Cancer

(IN BRIEF) AstraZeneca announces positive outcomes from the ADRIATIC Phase III trial, revealing that its immunotherapy drug Imfinzi (durvalumab) demonstrated a significant improvement in overall survival (OS) and progression-free survival (PFS) among patients with limited-stage small cell lung cancer (LS-SCLC) … Read the full press release

EIB Provides €25 Million Financing to Wandercraft for Personal Exoskeleton Development

(IN BRIEF) French medtech company Wandercraft secures €25 million financing from the European Investment Bank (EIB) to advance the development of their groundbreaking Personal Exoskeleton. This innovative device, the first self-balancing exoskeleton designed for daily use by individuals with severe … Read the full press release

FDA Approves Basilea’s ZEVTERA® for Severe Bacterial Infections, Including Pediatric Use

(IN BRIEF) Basilea Pharmaceutica Ltd, a biopharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for ZEVTERA® (ceftobiprole medocaril sodium for injection). The approval covers its use in adult patients with Staphylococcus aureus bloodstream infections (bacteremia), … Read the full press release

Unitaid Grants Additional Funding to University of Liverpool-led LONGEVITY Project for Long-Acting Infectious Disease Therapeutics

(IN BRIEF) Unitaid has allocated over £6 million in new funding to the University of Liverpool-led LONGEVITY project, aimed at enhancing long-acting therapeutics for tuberculosis, malaria, and hepatitis C. Started in 2020, the project has achieved preclinical milestones for long-acting … Read the full press release

CompuGroup Medical Welcomes New Digitization Experts to German Healthcare Sector

(IN BRIEF) CompuGroup Medical SE & Co. KGaA (CGM), a leading e-health provider, has announced the appointment of two renowned digitization experts in the German healthcare system. Max Müller has assumed leadership of the CLICKDOC & m.Doc business area, while … Read the full press release

Aviva Partners with Joe Wicks and Strava to Encourage Nationwide Wellbeing Revolution

(IN BRIEF) Aviva collaborates with fitness icon Joe Wicks and Strava to launch the #MoveWithAviva challenge, aiming to inspire individuals across the nation to prioritize their health and wellness. In response to findings revealing common barriers to exercise, such as … Read the full press release

University of Helsinki Launches Doctoral Researcher Positions Pilot Funded by Finnish Ministry

(IN BRIEF) The University of Helsinki has initiated a doctoral education pilot, sponsored by the Finnish Ministry of Education and Culture, offering three-year positions for doctoral researchers. With 236 vacancies across 11 sectoral pilots, the application period runs until April … Read the full press release